Treatment Outcomes and Patient Satisfaction of Oral Lichen Planus Treatment
Key facts
- Who runs it
- Dar Al Uloom University
- Where
- Saudi Arabia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 2
- People taking part
- 56 people enrolled
- Started
- 20 May 2025
- Ended
- 15 Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Honey in orabase 1: 1 paste
- Record updated
- 27 August 2026
Who can take part
- Age
- 35 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patients with a clinical diagnosis of oral lichen planus
- Symptomatic OLP lesions (erosive/atrophic)
- Participants are between 35 and 60 years old, who are able to adhere to the study protocol, and sign informed consent
Who cannot take part
- Patients who administer systemic corticosteroids or immunosuppressive agents
- Patients with other oral mucosal disorders, or systemic conditions influencing OLP or wound healing, allergies or hypersensitivity to honey or triamcinolone
- Pregnancy or lactation
- Inability to comprehend or adhere to study directives
- Patients who are not able to sign an informed written consent
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to assess Honey in orabase (1:1) for treating patients with OLP and improving their quality of life:
Read full original descriptionShow less
The research question aims to answer:
Does honey in orabase (1:1) improve or reduce OLP symptoms compared to the standardized treatment by triamcinolone acetonide 0.1% drug and improve the patient's quality of life?
Participants will:
Take drug ABC or a placebo every day for 4 months Visit the clinic once every 2 weeks for checkups and tests Keep a diary of their symptoms and the number of times they use a rescue inhaler
The 2 groups in the trial
- Group I with OLP at buccal mucosaTreatment being tested
The trial Group (I) (honey in orabase 1: 1 paste), four times daily after meals or rinsing
Treatment: Honey in orabase 1: 1 paste
- Group II with OLP at buccal mucosaExisting treatment, for comparison
Group (II): triamcinolone acetonide 0.1% ointment, four times daily after meals or rinsing
Treatment: Honey in orabase 1: 1 paste
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 27 August 2026